Abstract Details
|
Emanuele Barca, MD, PhD
(Columbia University)
PRESENTER |
Dr. Barca has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Valentina Emmanuele, MD, PhD (NYP at CUIMC) | No disclosure on file |
| Salvatore DiMauro, MD (Columbia University Medical Center) | No disclosure on file |
| Bruce H. Cohen, MD, FAAN (Akron Children's Hospital) | Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reneo Pharmaceuticals. Dr. Cohen has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuroene. Dr. Cohen has received personal compensation in the range of $0-$499 for serving as a Consultant for CoA Therapeutics/BioBridge. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abliva/NeuroVive. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis/Zogenix. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Pharmaceuticals. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision BioSciences . Dr. Cohen has received personal compensation in the range of $0-$499 for serving as a Consultant for Pretzel. The institution of Dr. Cohen has received research support from Stealth Biotherapeutics. The institution of Dr. Cohen has received research support from BioElectron Technologies/PTC. The institution of Dr. Cohen has received research support from Astellas/MitoBridge. The institution of Dr. Cohen has received research support from Reneo Pharmaceuticals. The institution of Dr. Cohen has received research support from Abliva. Dr. Cohen has received publishing royalties from a publication relating to health care. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant with US DOJ. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a CPT Advisor with AAN. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Society that is relevant to AAN interests or activities. Dr. Cohen has a non-compensated relationship as a Officer with Child Neurology Foundation that is relevant to AAN interests or activities. |
| No disclosure on file | |
| No disclosure on file | |
| Richard H. Haas, MD | No disclosure on file |
| Johan Van Hove | No disclosure on file |
| Fernando Scaglia, MD | No disclosure on file |
| Sumit Parikh, MD (Cleveland Clinic Neurological Institute) | Dr. Parikh has received personal compensation in the range of $0-$499 for serving as a Consultant for Epirium. The institution of Dr. Parikh has received research support from CHAMP. The institution of Dr. Parikh has received research support from Mitochondrial Medicine Society. The institution of Dr. Parikh has received research support from Minovia. The institution of Dr. Parikh has received research support from Acadia. The institution of Dr. Parikh has received research support from Stealth. Dr. Parikh has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| Suzanne D. DeBrosse, MD (University Hospitals Cleveland Medical Center) | No disclosure on file |
| Ralitza H. Gavrilova, MD (Mayo Clinic) | Dr. Gavrilova has nothing to disclose. |
| Russell P. Saneto, DO, PhD (Seattle Childrens Hospital) | Dr. Saneto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REATA. Dr. Saneto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GW Pharmaceuticals. The institution of Dr. Saneto has received research support from NIH. The institution of Dr. Saneto has received research support from Zogenix. The institution of Dr. Saneto has received research support from GW Pharmaceuticals. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Austin Larson | No disclosure on file |
| Zarazuela Zolkipli-Cunningham, MBChB (The Children's Hospital of Philadelphia, Human Genetics) | Dr. Zolkipli-Cunningham has nothing to disclose. |
| Marni Falk | No disclosure on file |
| Amy Goldstein, MD (Children's Hospital of Pittsburgh) | No disclosure on file |
| Mark Tarnopolsky, MD, PhD, FRCP (McMaster University) | Dr. Tarnopolsky has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Tarnopolsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reneo. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reneo . Dr. Tarnopolsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Tarnopolsky has stock in Synaptive Medical. Dr. Tarnopolsky has stock in CloudDx. The institution of Dr. Tarnopolsky has received research support from Canadian Institute for Health Research. Dr. Tarnopolsky has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| No disclosure on file | |
| Kristin Engelstad | No disclosure on file |
| Xiomara Q. Rosales, MD (Columbia University Medical Center-Neuromuscular Division) | No disclosure on file |
| No disclosure on file | |
| Richard Buchsbaum | No disclosure on file |
| John L. Thompson, PhD (Columbia Univ School of Public Health) | The institution of Dr. Thompson has received research support from NIH. |
| Michio Hirano, MD, FAAN (Columbia University Medical Center) | Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics (a subsidiary of Zogenix). Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Innovation Specialist. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Platform Q Health. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Modis Therapeutics (a subsidiary of Zogenix. The institution of Dr. Hirano has received research support from Cyclerion. Dr. Hirano has received research support from Reneo Pharmaceuticals. The institution of Dr. Hirano has received research support from Astellas. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities. |